MF40 Automated Punch and Die Polishing Machine - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

MF40 Automated Punch and Die Polishing Machine

Pharmaceutical Technology
Volume 37, Issue 9, pp. 14
I Holland MF40 Punch and Die Polishing

I Holland has introduced the next generation to its range of MF polishers, the MF40 automated punch, and die polishing machine. The stainless-steel construction is highly durable and easy to clean, according to the company.  A 40 L media drum and increased capacity holders allow for up to17 B or 12 D punches per holder giving a maximum of 51 B or 36 D punches per polishing cycle.  The MF40 uses single-phase power and fits in the same compact 940 x 750 mm footprint as the MF35. The MF40 polishing machine was developed to be used as part of I Holland’s PharmaCare 7-Step Process, a professional maintenance and storage program.

I Holland

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here